Solventum Corp

NYSE:SOLVHealthcareSTOXX:EDD24BPrussell1000

$86.34+1.52%LiveIn session · ≈ AED 317.08 · Market cap $14.7B · Next earnings Thu 5 Nov

SOLV · Income statement · TradingHolo

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Revenue	7.3	8.2	8.1	8.2	8.3	8.3	8.3	−0.2%
Cost of revenue	3.0	3.2	3.4	3.5	3.7	3.9	3.7	−3.8%
Gross profit	4.3	4.9	4.7	4.7	4.6	4.5	4.5	+2.1%
Research & development	0.7	0.8	0.8	0.8	0.8	0.7	0.7	−1.9%
Selling, general & administrative	2.2	2.3	2.2	2.2	2.8	3.1	—	—
Selling & marketing	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Operating expenses	2.9	3.0	3.0	3.0	3.6	2.3	—	—
Operating income	1.4	1.9	1.7	1.7	1.0	2.2	2.1	−4.8%
Interest expense	0.0	0.0	0.0	0.0	0.4	0.3	0.3	−23.3%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other income / expense	0.0	0.0	(0.0)	(0.0)	(0.4)	(0.5)	—	—
Pre-tax income	1.4	1.9	1.7	1.7	0.6	1.7	1.7	−1.0%
Income tax	0.3	0.4	0.3	0.3	0.1	0.2	0.3	+66.2%
Net income	1.1	1.5	1.3	1.3	0.5	1.6	1.4	−7.8%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—	—
EPS, basic (per share)	6.60	8.47	7.79	7.79	2.77	8.94	8.22	−8.0%
EPS, diluted (per share)	6.60	8.47	7.79	7.79	2.76	8.88	8.18	−7.9%
EBITDA	2.0	2.5	2.3	2.2	1.5	2.5	2.6	+1.2%
Depreciation & amortization	0.6	0.6	0.6	0.6	0.6	0.5	0.5	+3.5%
Weighted average shares (shares)	172,466,022	172,466,022	172,466,022	172,709,505	173,200,000	174,100,000	—	—
Weighted average diluted shares (shares)	172,466,022	172,466,022	172,466,022	172,709,505	173,700,000	175,300,000	—	—
Gross margin	59.3%	60.2%	57.7%	57.3%	55.6%	53.5%	54.7%	+1.2 pts
Operating margin	19.6%	23.0%	20.8%	20.6%	12.6%	26.2%	25.0%	−1.2 pts
Net margin	15.6%	17.9%	16.5%	16.4%	5.8%	18.7%	17.3%	−1.4 pts

USD billionsUpdated Wed 5 Aug ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-06-30 and uses four consecutive reported quarters.